165
Participants
Start Date
June 7, 2023
Primary Completion Date
November 15, 2024
Study Completion Date
June 16, 2027
eneboparatide
Supplied as a solution (concentration of 250 mcg/mL or 500 mcg/mL) in single-patient-use prefilled pens
Placebo
Placebo is supplied as a solution (containing the excipient solution for eneboparatide) in single-patient-use prefilled pens
Semmelweis Egyetem Belgyogyaszati es Hematologiai Klinika, Budapest
Leiden University Medical Center, Leiden
Pecsi Tudomanyegyetem, Pécs
Aarhaus University Hospital, Aarhus
Colombia University Irving Medical Center, New York
Hopital de la Conception-APHM, Marseille
Complejo Hospitalario Universitario de A Coruna, A Coruña
The Children's Hospital of Philadelphia (CHOP), Philadelphia
The Children's Hospital of Philadephia, Philadelphia
Thomas Jefferson University, Philadelphia
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan
Physician's East Endocrinology, Greenville
Clinica Universidad de Navarra, Pamplona
Azienda Ospedaliero Universitaria de Bologna, Policlinico Sant Orsola Malpighi, Bologna
Hospital Universitario Virgen del Rocio, Seville
The Ohio State University Wexner Medical Center, Columbus
CHU de Nantes - Hôtel-Dieu, Nantes
Indiana University (IU) Health University Hospital, Indianapolis
Azienda Ospedaliera Universitaria Careggi, Florence
Mayo Clinic, Rochester
Azienda Ospedaliera Universitaria Pisana-Ospedale di Cisanello, Pisa
North Shore University Health System, Evanston
University of Chicago - Medical Center, Chicago
Academy of Diabetes, Thyroid and Endocrine, El Paso
Denver Endocrinology Diabetes and Thyroid Center, Denver
Medicover Neuroendokrinologie MVZ, Munich
Northern Nevada Endocrinology, Reno
Harbor UCLA Medical Center Endocrinology, Torrance
Hospital Bicetre AP-HP, Paris
Universitaetsklinikum Wuerzburg, Würzburg
Arthritis Northwest, PLLC, Spokane
Massachusetts General Hospital, Boston
Eastern Regional Health Authority Health Sciences Centre, St. John's
Bone Research and Education Center, Oakville
CHU de Quebec Research Centre, Québec
Rigshospitalet, Copenhagen
Teikyo University Chiba Medical Center, Chiba
Kanazawa University Hospital, Kanazawa
Osaka City Hospital, Osaka
Osaka Metropolital University Hospital, Osaka
Tokushima University Hospital, Tokushima
Tottori University Hospital, Tottori
Universitatsklinikum Carl Gustav Carus an der TU Dresden, Dresden
Via Alvaro del Portillo, 200, Roma, Italy 00128, Roma
Eramus MC - University Medical Center, Rotterdam
Medycyny Nuklearnej i Chorob Wewnetrznych, Krakow
Instytut Centrum Zdrowia Matki Polki. Klinika Endokrynologii Chorob Metabolicznych, Lodz
Cendrum Zdrowi MDM - EB Group Sp., Warsaw
Hospital da Luz Lisboa, Lisbon
Centro Hospital Vila Nova de Faia/Espinho, Porto
Hospital Universitari Vall d'Hebron, Barcelona
University Hospitals of Leicester NHS Trust, Leicester
Norfolk & Norwich University NHS Foundation Trust, Quadrum Institute, Norwich
Churchill Hospital, Oxford
Lead Sponsor
Collaborators (1)
Amolyt Pharma
INDUSTRY
Alexion Pharmaceuticals, Inc.
INDUSTRY